Phanes Therapeutics’ anti-claudin 18.2 antibody patent granted in the US
Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that the U.S. Patent and Trademark…
Read More...
Read More...
